Early Control of H5N1 Influenza Virus Replication by the Type I Interferon Response in Mice

ABSTRACT Widespread distribution of highly pathogenic avian H5N1 influenza viruses in domesticated and wild birds continues to pose a threat to public health, as interspecies transmission of virus has resulted in increasing numbers of human disease cases. Although the pathogenic mechanism(s) of H5N1 influenza viruses has not been fully elucidated, it has been suggested that the ability to evade host innate responses, such as the type I interferon response, may contribute to the virulence of these viruses in mammals. We investigated the role that type I interferons (alpha/beta interferon [IFN-α/β]) might play in H5N1 pathogenicity in vivo, by comparing the kinetics and outcomes of H5N1 virus infection in IFN-α/β receptor (IFN-α/βR)-deficient and SvEv129 wild-type mice using two avian influenza A viruses isolated from humans, A/Hong Kong/483/97 (HK/483) and A/Hong Kong/486/97 (HK/486), which exhibit high and low lethality in mice, respectively. IFN-α/βR-deficient mice experienced significantly more weight loss and more rapid time to death than did wild-type mice. HK/486 virus caused a systemic infection similar to that with HK/483 virus in IFN-α/βR-deficient mice, suggesting a role for IFN-α/β in controlling the systemic spread of this H5N1 virus. HK/483 virus replicated more efficiently than HK/486 virus both in vivo and in vitro. However, replication of both viruses was significantly reduced following pretreatment with IFN-α/β. These results suggest a role for the IFN-α/β response in the control of H5N1 virus replication both in vivo and in vitro, and as such it may provide some degree of protection to the host in the early stages of infection.

[1]  John Steel,et al.  Influenza A Virus Strains Differ in Sensitivity to the Antiviral Action of Mx-GTPase , 2008, Journal of Virology.

[2]  Guohua Deng,et al.  A Single-Amino-Acid Substitution in the NS1 Protein Changes the Pathogenicity of H5N1 Avian Influenza Viruses in Mice , 2007, Journal of Virology.

[3]  N. Cox,et al.  Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice. , 2007, Virus research.

[4]  G. Kochs,et al.  The Mx1 Gene Protects Mice against the Pandemic 1918 and Highly Lethal Human H5N1 Influenza Viruses , 2007, Journal of Virology.

[5]  R. Krug,et al.  The H5N1 Influenza Virus NS Genes Selected after 1998 Enhance Virus Replication in Mammalian Cells , 2007, Journal of Virology.

[6]  G. Kochs,et al.  Multiple Anti-Interferon Actions of the Influenza A Virus NS1 Protein , 2007, Journal of Virology.

[7]  S. Goodbourn,et al.  NS1 Proteins of Avian Influenza A Viruses Can Act as Antagonists of the Human Alpha/Beta Interferon Response , 2006, Journal of Virology.

[8]  T. Tumpey,et al.  Role of Host Cytokine Responses in the Pathogenesis of Avian H5N1 Influenza Viruses in Mice , 2006, Journal of Virology.

[9]  J. Hoofnagle,et al.  Peginterferon and ribavirin for chronic hepatitis C. , 2006, The New England journal of medicine.

[10]  Yi Guan,et al.  Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia , 2006, Nature Medicine.

[11]  P. Fisher,et al.  Retinoic acid inducible gene-I and mda-5 are involved in influenza A virus-induced expression of antiviral cytokines. , 2006, Microbes and infection.

[12]  J. Tschopp,et al.  Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. , 2006, Molecular cell.

[13]  R. Webby,et al.  Influenza virus NS1 protein protects against lymphohematopoietic pathogenesis in an in vivo mouse model. , 2006, Virology.

[14]  S. Goodbourn,et al.  Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. , 2006, Virology.

[15]  R. Webster,et al.  The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04 , 2006, The Journal of experimental medicine.

[16]  P. Österlund,et al.  TNF-α and IFN-α enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells , 2006 .

[17]  R. Webster,et al.  Molecular Basis of Replication of Duck H5N1 Influenza Viruses in a Mammalian Mouse Model , 2005, Journal of Virology.

[18]  N. Cox,et al.  Avian Influenza (H5N1) Viruses Isolated from Humans in Asia in 2004 Exhibit Increased Virulence in Mammals , 2005, Journal of Virology.

[19]  B. Stevenson,et al.  Current Protocols in Microbiology , 2005 .

[20]  R. Webster,et al.  Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses. , 2005, The Journal of general virology.

[21]  S. Dowell,et al.  Human Disease from Influenza A (H5N1), Thailand, 2004 , 2005, Emerging infectious diseases.

[22]  R. Webster,et al.  The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses. , 2004, Virus research.

[23]  Shizuo Akira,et al.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.

[24]  Constance Schultsz,et al.  Avian influenza A (H5N1) in 10 patients in Vietnam. , 2004, The New England journal of medicine.

[25]  Yoshihiro Kawaoka,et al.  PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice. , 2004, Virology.

[26]  J. Peiris,et al.  Re-emergence of fatal human influenza A subtype H5N1 disease , 2004, The Lancet.

[27]  P. Klenerman,et al.  The influence of macrophage inflammatory protein‐1α on protective immunity mediated by antiviral cytotoxic T cells , 2003, Immunology.

[28]  R. Krug,et al.  Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS. , 2003, Virology.

[29]  Thorsten Wolff,et al.  The Influenza A Virus NS1 Protein Inhibits Activation of Jun N-Terminal Kinase and AP-1 Transcription Factors , 2002, Journal of Virology.

[30]  J. Darnell,et al.  Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.

[31]  R. Webster,et al.  Lethal H5N1 influenza viruses escape host anti-viral cytokine responses , 2002, Nature Medicine.

[32]  Y. Guan,et al.  Molecular changes associated with the transmission of avian influenza a H5N1 and H9N2 viruses to humans * , 2002, Journal of medical virology.

[33]  Marc Dalod,et al.  Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology , 2001, Nature Immunology.

[34]  M. Shaw,et al.  Molecular correlates of influenza A H5N1 virus pathogenesis in mice. , 2001, Journal of virology.

[35]  Yoshihiro Kawaoka,et al.  Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses , 2001, Science.

[36]  W. Barclay,et al.  Sequences in Influenza A Virus PB2 Protein That Determine Productive Infection for an Avian Influenza Virus in Mouse and Human Cell Lines , 2001, Journal of Virology.

[37]  P. Massin,et al.  Residue 627 of PB2 Is a Determinant of Cold Sensitivity in RNA Replication of Avian Influenza Viruses , 2001, Journal of Virology.

[38]  Amer A. Beg,et al.  Influenza A Virus NS1 Protein Prevents Activation of NF-κB and Induction of Alpha/Beta Interferon , 2000, Journal of Virology.

[39]  I. Julkunen,et al.  Influenza A and sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages. , 2000, Virology.

[40]  T. Tumpey,et al.  Depletion of Lymphocytes and Diminished Cytokine Production in Mice Infected with a Highly Virulent Influenza A (H5N1) Virus Isolated from Humans , 2000, Journal of Virology.

[41]  K. Akakura,et al.  Laparoscopic adrenalectomy for functioning adrenal tumors: clinical experiences with 38 cases and comparison with open adrenalectomy. , 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[42]  K. Omoe,et al.  Evolutionary characterization of the six internal genes of H5N1 human influenza A virus. , 2000, The Journal of general virology.

[43]  T. Tumpey,et al.  Pathogenesis of and immunity to avian influenza A H5 viruses. , 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[44]  N. Cox,et al.  A Mouse Model for the Evaluation of Pathogenesis and Immunity to Influenza A (H5N1) Viruses Isolated from Humans , 1999, Journal of Virology.

[45]  R. Krug,et al.  Influenza A virus NS1 protein targetspoly(A)‐binding protein II of the cellular 3′‐end processing machinery , 1999, The EMBO journal.

[46]  H. Goto,et al.  Biological Heterogeneity, Including Systemic Replication in Mice, of H5N1 Influenza A Virus Isolates from Humans in Hong Kong , 1999, Journal of Virology.

[47]  D. Levy,et al.  Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. , 1998, Virology.

[48]  R. Webster,et al.  Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice. , 1998, The Journal of infectious diseases.

[49]  A. García-Sastre,et al.  The Role of Interferon in Influenza Virus Tissue Tropism , 1998, Journal of Virology.

[50]  M. Katze,et al.  Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[51]  M. Peiris,et al.  Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus , 1998, The Lancet.

[52]  F. Hayden,et al.  Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. , 1998, The Journal of clinical investigation.

[53]  D. Gemsa,et al.  Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response , 1997, Journal of leukocyte biology.

[54]  R. Krug,et al.  The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses. , 1996, Virology.

[55]  C. Samuel,et al.  Mechanism of interferon action: double-stranded RNA-specific adenosine deaminase from human cells is inducible by alpha and gamma interferons. , 1995, Virology.

[56]  M Aguet,et al.  Functional role of type I and type II interferons in antiviral defense. , 1994, Science.

[57]  B. Murphy,et al.  A single amino acid in the PB2 gene of influenza A virus is a determinant of host range , 1993, Journal of virology.

[58]  Robert H. Silverman,et al.  Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action , 1993, Cell.

[59]  H. Gendelman,et al.  Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120 , 1992, Journal of virology.

[60]  R. Kumar,et al.  Cloning, sequencing, and expression of two murine 2'-5'-oligoadenylate synthetases. Structure-function relationships. , 1991, The Journal of biological chemistry.

[61]  I. Kerr,et al.  Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon , 1990, Cell.

[62]  R. Friedman,et al.  Interferon induces the production of membrane protein-deficient and infectivity-defective vesicular stomatitis virions through interference in the virion assembly process. , 1983, The Journal of general virology.

[63]  N. Roberts,et al.  Virus-induced interferon production by human macrophages. , 1979, Journal of immunology.

[64]  M. Peiris Pathogenesis of avian flu H5N1 and SARS. , 2006, Novartis Foundation symposium.

[65]  K. Melén,et al.  TNF-alpha and IFN-alpha enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells. , 2006, Virology.

[66]  S. Baron,et al.  Interferon inhibits C-type virus at a posttranscriptional, prerelease step , 2005, Archives of Virology.

[67]  Cases of influenza A (H5N1)--Thailand, 2004. , 2004, MMWR. Morbidity and mortality weekly report.

[68]  L. Ratner,et al.  Alpha Interferon Inhibits Human T-Cell Leukemia Virus Type 1 Assembly by Preventing Gag Interaction with Rafts , 2003 .

[69]  Subrata,et al.  Cloning , Sequencing , and Expression of Two Murine 2 ’-5 ’-Oligoadenylate Synthetases , 2001 .

[70]  M. Caron,et al.  Structure-Function Relationships , 1991 .

[71]  O. Haller,et al.  Interferon-induced Mx protein: a mediator of cellular resistance to influenza virus. , 1987, Interferon.

[72]  Y. H. Wu,et al.  Antiretroviral effect of interferon: proposed mechanism. , 1982, Journal of interferon research.